Effectiveness and safety of edoxaban in patients with atrial fibrillation: data from the Danish Nationwide Cohort — Peter Brønnum Nielsen (2019) | RDL Network
Effectiveness and safety of edoxaban in patients with atrial fibrillation: data from the Danish Nationwide Cohort
Article 2019 en
Authors
PN
Peter Brønnum Nielsen
TL
Torben Bjerregaard Larsen
FS
Flemming Skjøth
Abstract
1 min read
In this nationwide cohort of Caucasian AF patients treated with edoxaban for stroke prevention, the clinical effectiveness and safety were in line with data from the ENGAGE AF-TIMI 48 trial. Studies investigating comparative effectiveness and safety for edoxaban in comparison with other choices of antithrombotic treatment options are needed.
Discussion(0)
No comments yet. Be the first to comment.